Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 1/20 | 0.49 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.48 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.45 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.44 |
| ▸ | CDK8 | P49336 | 1/20 | 0.44 |
| ▸ | NEK2 | P51955 | 1/20 | 0.44 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.41 |
| ▸ | MPL | P40238 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL31385186 | 1.00 | CTRB1 (0.49) | CTRB1PTPN22LDHAERN1THRB | |
| SCHEMBL2880574 | 0.98 | PTPN22 (0.50) | CTRB1PTPN22LDHAERN1THRB | |
| SCHEMBL8445295 | 0.96 | CTRB1 (0.49) | CTRB1PTPN22LDHAERN1THRB | |
| SCHEMBL3169181 | 0.96 | CTRB1 (0.49) | CTRB1PTPN22LDHAERN1THRB | |
| SCHEMBL339569 | 0.96 | CTRB1 (0.49) | CTRB1PTPN22LDHAERN1THRB | |
| Hydrochloric Acid SCHEMBL27766336 | 0.81 | CTRB1 (0.64) | CTRB1PTPN22LDHAERN1CHEK1 | |
| SCHEMBL30383446 | 0.81 | CTRB1 (0.64) | CTRB1PTPN22LDHAERN1CHEK1 | |
| SCHEMBL88069 | 0.81 | CTRB1 (0.64) | CTRB1PTPN22LDHAERN1CHEK1 | |
| Potassium Ion SCHEMBL3628026 | 0.81 | DNMT1 (0.44) | CTRB1THRBNR4A1F2PRSS1 | |
| Potassium SCHEMBL2292044 | 0.79 | CTRB1 (0.62) | CTRB1PTPN22LDHAERN1CHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2218754-B1 | POLYIMIDE COMPOSITE MATERIAL AND FILM OF THE SAME | MITSUI CHEMICALS INC (JP) | 2018-06-20 | — | — | EP | disclosed |
| US-9540487-B2 | Polyimide composite material and film thereof | MITSUI CHEMICALS, INC. (JP) | 2017-01-10 | — | — | US | disclosed |
| US-8501981-B2 | CXCR2 inhibitors | SANOFI (FR) | 2013-08-06 | — | — | US | disclosed |
| US-20110190309-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST | PULMAGEN THERAPEUTICS (SYNERGY) LIMITED (GB) | 2011-08-04 | — | — | US | disclosed |
| EP-2315589-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A beta2-ADRENOCEPTOR AGONIST | AstraZeneca AB (SE) | 2011-05-04 | — | — | EP | disclosed |
| US-20100304160-A1 | POLYIMIDE COMPOSITE MATERIAL AND FILM THEREOF | MITSUI CHEMICALS, INC. (JP) | 2010-12-02 | — | — | US | disclosed |
| EP-2218754-A1 | POLYIMIDE COMPOSITE MATERIAL AND FILM OF THE SAME | Mitsui Chemicals, Inc. (JP) | 2010-08-18 | — | — | EP | disclosed |
| US-20100056547-A1 | OPHTHALMIC COMPOSITIONS COMPRISING dDC | ALLERGAN, INC. (US) | 2010-03-04 | — | — | US | disclosed |
| WO-2009139707-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT | ASTRAZENECA AB (SE) | 2009-11-19 | — | — | WO | disclosed |
| WO-2009139708-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST | ASTRAZENECA AB (SE) | 2009-11-19 | — | — | WO | disclosed |
| EP-0137521-B1 | INTEGRAL MULTILAYER ELEMENT FOR CHEMICAL ANALYSIS | FUJI PHOTO FILM CO., LTD. (JP) | 1989-09-27 | — | — | EP | disclosed |
| US-4781890-A | LIGHT-BLOCKING LAYER, TITANIUM DIOXIDE; FLUORIDE SALT-FORMING CATION | FUJI PHOTO FILM CO., LTD. (JP) | 1988-11-01 | — | — | US | disclosed |
| EP-0243126-A2 | Method of measuring hydrogen peroxide or of measuring an enzyme or biochemical substrate liberating the peroxide | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1987-10-28 | — | — | EP | disclosed |
| US-4681841-A | CONSUMING OXYGEN OR GENERATING A PIGMENT; MEASUREMENT BY AN OXYGEN ELECTRODE OR COLORIMETRIC ASSAY | TOYO JOZO KABUSHIKI KAISHA (JP) | 1987-07-21 | — | — | US | disclosed |
| US-4675290-A | CHROMATOGRAPHY OF THE ANILINE DYE PRODUCED BY COUPLING REACTI ON OF THE AMINE FORMED FROM THE AMIDE SUBSTRATE | TOYO JOZO KABUSHIKI KAISHA (JP) | 1987-06-23 | — | — | US | disclosed |
| US-4588836-A | LEUCYL- OR GLUTAMYL-3,5-DIHALO-4-HYDROXYANILIDES | TOYO JOZO KABUSHIKI KAISHA (JP) | 1986-05-13 | — | — | US | disclosed |
| US-4551272-A | Derivatives of dipeptide and their use in determining the activity of carboxypeptidase A | FUJIREBIO KABUSHIKI KAISHA (JP) | 1985-11-05 | — | — | US | disclosed |
| EP-0137521-A2 | Integral multilayer element for chemical analysis | FUJI PHOTO FILM CO., LTD. (JP) | 1985-04-17 | — | — | EP | disclosed |
| US-4295853-A | EXTRACTING LIPOPEROXIDE FROM BLOOD OR SERUM, OXIDIZABLE COLOR REAGENT, COMPOUND OF MULTIVALENT METAL | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1981-10-20 | — | — | US | disclosed |
| US-4042335-A | Integral element for analysis of liquids | EASTMAN KODAK COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190309-A1 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONIST | ADRB2, ADRB1, ADRA2A | CTRB1 2061/4885PTPN22 2960/4885LDHA 3667/4885 |
| US-20100056547-A1 | OPHTHALMIC COMPOSITIONS COMPRISING dDC | PDE6C, DDC, PDE6H | CTRB1 1122/4885PTPN22 906/4885LDHA 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.